CAGRERA 5 mg
Cagrilintide
A long-acting, non-selective amylin receptor agonist for metabolic and receptor-signaling research.
This product is being prepared for release. Pricing and availability will be confirmed before ordering opens.
Every compound vial includes one 3 mL BAC Water and one compound / BAC pair holder.
Research Use Only (RUO)
For controlled laboratory and analytical research only. Not for human or veterinary use. Study findings describe experimental materials and models, not verified effects of this product.
What is CAGRERA?
CAGRERA features Cagrilintide, a synthetic analogue of the pancreatic hormone amylin. Its receptor activity is investigated in studies of satiety signaling, gastric emptying and glucose homeostasis through pathways distinct from incretin signaling.
Research includes amylin and calcitonin receptor pharmacology and combination approaches with incretin agonists. Findings from specific experimental combinations do not establish the effects, compatibility or safety of combining MGMT Research products.
Specifications & reporting
- Compound
- Cagrilintide
- Selected vial amount
- 5 mg
- Format
- Lyophilized research material
- Batch / lot
- Not assigned
- COA
- Pending · no batch results posted
No purity, net-content or batch-testing result is claimed before a matching laboratory report is posted. Handling and stability depend on the material and experimental conditions; confirm lot-specific documentation before laboratory work.
Product labels
Black, silver and teal artwork with blank LOT / MFG / EXP fields. Packaging concept, 40 × 20 mm layout.
Selected research
References are provided for research context. They do not establish the safety or efficacy of this product for human use.